SCHEMBL1011994

SCHEMBL1011994

CC(C)(C)c1cc(NC(=O)Nc2cccc(Sc3ncnc4ccc(OCCCN5CCSC(=O)C5=O)cc34)c2)no1

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRAF P15056 19/20 0.73
RAF1 P04049 15/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015120 0.86 BRAF (0.76) BRAFRAF1
SCHEMBL1780730 0.85 BRAF (1.00) BRAFRAF1
SCHEMBL17046528 0.84 BRAF (0.81) BRAFRAF1
SCHEMBL1012324 0.83 BRAF (1.00) BRAFRAF1
SCHEMBL18660163 0.82 BRAF (0.78) BRAFRAF1
SCHEMBL1012223 0.81 BRAF (1.00) BRAFRAF1
SCHEMBL1012725 0.78 BRAF (0.76) BRAFRAF1
SCHEMBL1012919 0.78 BRAF (0.76) BRAFRAF1
SCHEMBL13680221 0.78 BRAF (0.87) BRAFRAF1
SCHEMBL18676498 0.78 BRAF (0.87) BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2011529021-A 2011-12-01 JP claimed
EP-2268623-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2011-01-05 EP claimed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO claimed
EP-2268623-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2011-01-05 EP disclosed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO disclosed